Currently out of the existing stock ratings of Randall Stanicky, 82 are a HOLD (33.33%), 154 are a BUY (62.6%), 10 are a SELL (4.07%).

Randall Stanicky

Work Performance Price Targets & Ratings Chart

Analyst Randall Stanicky, carries an average stock price target met ratio of 41.83% that have a potential upside of 45.1% achieved within 289 days. Previously, Randall Stanicky worked at RBC.

Randall Stanicky’s has documented 437 price targets and ratings displayed on 27 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on ABBV, AbbVie at 06-Apr-2021.

Wall Street Analyst Randall Stanicky

Analyst best performing recommendations are on AGRX (AGILE THRPE).
The best stock recommendation documented was for AGRX (AGILE THRPE) at 10/31/2019. The price target of $4000 was fulfilled within 5 days with a profit of $1600 (66.67%) receiving and performance score of 133.33.

Average potential price target upside

of $37.77 (29.43%) on JAZZ (JAZZ PHARMACEUTICALS PLC).
of $35.85 (47.06%) on ABBV (ABBVIE).
of $20.29 (30.85%) on MRK (MERCK MPANY).

ABBV AbbVie ACRX AcelRx Pharmaceuticals AGN Allergan plc AGRX Agile Thrpe AKRX Akorn AMRX Amneal Pharmaceuticals, Common Stock EGRX Eagle Pharmaceuticals ENDP Endo International PLC FLXN Flexion Therapeutics INSY INSYS Therapeutics JAZZ Jazz Pharmaceuticals PLC KMPH KemPharm MRK Merck mpany MYL Viatris OSMT Osmotica Pharmaceuticals plc PCRX Pacira Pharmaceuticals PFE Pfizer PRGO Perrigo Company PLC SGNT Sagent Pharmaceuticals TEVA Teva Pharma Industries Ltd ADR VTRS Viatris XERS Xeris Pharmaceuticals AQST Aquestive Therapeutics ASRT Assertio Therapeutics NEOS Neos Therapeutics OPTN OptiNose RVLP RVL Pharmaceuticals PLC

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Vamil Divan (GUGGENHEIM)